Exhibit 10.14
Confidential Materials omitted and filed separately with the Securities
and Exchange Commission. Asterisks denote omissions.
AMENDMENT NO. 4
to
AGREEMENT
by and between
XXXXX XX AND MILLENNIUM PHARMACEUTICALS, INC.
This is Amendment No. 4, dated as of December 1, 2000 ("Amendment No.
4"), to the Agreement, dated as of September 22, 1998 and as subsequently
amended (the "Agreement"), by and between Xxxxx XX, located at D 00000
Xxxxxxxxxx, Xxxxxxx and Millennium Pharmaceuticals, Inc., located at 00 Xxxxxx
Xxxxxx, Xxxxxxxxx, Xxxxxxxxxxxxx 00000.
INTRODUCTION
The Parties have determined that it is in their mutual best interests
to amend the Agreement in the manner set forth below.
Accordingly, in accordance with Section 11.5 of the Agreement, the
Parties agree to amend the Agreement as follows:
1. Use of Terms. Capitalized terms used herein and not defined herein
shall have the respective meanings ascribed to such terms in the Agreement.
2. Exhibit D. Exhibit D of the Agreement is hereby amended by
deleting Exhibit D in its entirety and by substituting the following in its
place:
Program Payment Schedule
Date Payment Due
---- -----------
February 1, 1999 $[**]
May 1, 1999 $[**]
August 1, 1999 $[**]
November 1, 1999 $[**]
December 1, 1999 $[**]
February 1, 2000 $[**]
May 1, 2000 $[**]
August 1, 2000 $[**]
Confidential Materials omitted and filed separately with the Securities
and Exchange Commission. Asterisks denote omissions.
November 1, 2000 $[**]
December 8, 2000 $[**]
February 1, 2001 $[**]
May 1, 2001 $[**]
August 1, 2001 $[**]
November 1, 2001 $[**]
February 1, 2002 $[**]
May 1, 2002 $[**]
August 1, 2002 $[**]
November 1, 2002 $[**]
February 1, 2003 $[**]
May 1, 2003 $[**]
August 1, 2003 $[**]
2. General. In all other respects, the Agreement is hereby ratified and
confirmed.
IN WITNESS WHEREOF, the Parties have executed this Amendment No. 4 as
of the date set forth above.
XXXXX XX
By: /s/ XXXXXXXX XXXXXXX
-----------------------------
Title: Prof. Xx. Xxxxxxxx Xxxxxxx
By: /s/ XXXXXX XXXXXX
-----------------------------
Title: Senior Counsel
MILLENNIUM PHARMACEUTICALS, INC.
By: /s/ XXXXX XXXXX
-----------------------------
Title: Chief Financial Officer
-2-
